In addition, carbohydrate vaccines, including a pentavalent vaccine (Globo-H-GM2-sTn-TF-Tn) and a heptavalent vaccine (GM2-Globo-H-Lewis Y-Tn-sTn-TF-Tn-MUC1), have successfully elicited IgG and/or IgM responses in ovarian cancer patients [223, 224]. This evidence concerns the gene TF and ovarian carcinoma.